Zheng Chen - Genovate Biotechnology General Manager, Director
| 4130 Stock | TWD 21.85 0.05 0.23% |
Director
Zheng Chen was serving as Chairman of the Board and Chief Strategy Officer in Genovate Biotechnology Co., Ltd. since July 5, 2017. Chen used to be Chairman of the Board in the Company. Chen holds a Ph.D. in Chemistry from University of Rochester, the United States. Chen also serves as NonExecutive Independent Director in another company, Chairman of the Board in a company, as well as Director in four other companies including BioResource International, Inc., and SyneuRx Imitational Corporationration since 2017.
| Age | 71 |
| Tenure | 7 years |
| Professional Marks | Ph.D |
| Phone | 886 3 598 2221 |
| Web | https://www.genovate-bio.com |
Genovate Biotechnology Management Efficiency
Genovate Biotechnology's management efficiency ratios could be used to measure how well Genovate Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 12 records | DIRECTOR Age | ||
| Yunqi Yan | Highwealth Construction Corp | N/A | |
| Yulun Liang | Chiu Ting Machinery | N/A | |
| Taihong Chen | Chiu Ting Machinery | N/A | |
| Zhuozhen Zhang | Chiu Ting Machinery | N/A | |
| Xiyao Hong | Highwealth Construction Corp | N/A | |
| Youyi Luo | Chiu Ting Machinery | N/A | |
| HuaChun Fan | Highwealth Construction Corp | N/A | |
| Y Lee | First Insurance Co | N/A | |
| Weixian Zhou | Chiu Ting Machinery | N/A | |
| Chaoguang Liu | Chiu Ting Machinery | N/A | |
| Wencheng Li | Highwealth Construction Corp | N/A | |
| Edward Lee | First Insurance Co | N/A | |
Management Performance
| Return On Equity | 0.0022 | |||
| Return On Asset | 0.0015 |
Genovate Biotechnology Leadership Team
Elected by the shareholders, the Genovate Biotechnology's board of directors comprises two types of representatives: Genovate Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genovate. The board's role is to monitor Genovate Biotechnology's management team and ensure that shareholders' interests are well served. Genovate Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genovate Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ming Peng, Deputy Operations | ||
| Zheng Chen, General Manager, Director |
Genovate Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genovate Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0022 | |||
| Return On Asset | 0.0015 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 3.16 B | |||
| Shares Outstanding | 109.38 M | |||
| Shares Owned By Insiders | 3.95 % | |||
| Shares Owned By Institutions | 26.96 % | |||
| Price To Book | 2.62 X | |||
| Price To Sales | 9.42 X |
Pair Trading with Genovate Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genovate Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genovate Biotechnology will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Genovate Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genovate Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genovate Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genovate Biotechnology Co to buy it.
The correlation of Genovate Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genovate Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genovate Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genovate Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Genovate Stock Analysis
When running Genovate Biotechnology's price analysis, check to measure Genovate Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovate Biotechnology is operating at the current time. Most of Genovate Biotechnology's value examination focuses on studying past and present price action to predict the probability of Genovate Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovate Biotechnology's price. Additionally, you may evaluate how the addition of Genovate Biotechnology to your portfolios can decrease your overall portfolio volatility.